HB 932 Maryland House of Delegates · 2024 Regular Session

Health Insurance - Utilization Review - Revisions

This Maryland bill updates health insurance rules to improve how prior authorization requests are handled and to ensure patients receive clearer cost information. It requires insurance companies to create online systems that allow doctors to submit and receive approval for drug coverage electronically, while also displaying real-time out-of-pocket costs and cheaper medication options at the point of prescribing. The law further prohibits insurers from charging fees for accessing these digital tools and restricts their ability to use provider data without consent. Additionally, the bill removes prior authorization requirements for specific prescription drugs used to treat opioid use disorder, such as methadone, buprenorphine, and naltrexone. These changes aim to streamline the approval process and increase transparency for both healthcare providers and insured individuals.
Bill status signed all 5 stages cleared
Introduction
Feb 2024
Committee Review
Apr 2024
House of Delegates Passage
Apr 2024
Senate Passage
Apr 2024
Signed into Law
May 2024
Introduced Feb 2, 2024 Signed May 16, 2024
Floor votes · Senate Mar 17, 2024 · House of Delegates Mar 25, 2024

How they voted

44–0
Passed · 1 other
Total votes 45
Mar 17, 2024
D Democratic32
31 Yea 1
96% Yea
R Republican13
13 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
17
Key actions
11
Committee
6
Amendments
1
May 16, 2024
Signed into law
Approved by the Governor - Chapter 847
executive
Apr 5, 2024
Lower · Passed
Passed Enrolled
lower
Apr 5, 2024
Lower · Passed
Third Reading Passed
lower
Apr 5, 2024
Introduced
House Concurs Senate Amendments
lower
Apr 3, 2024
Upper · Passed
Third Reading Passed
upper
Apr 2, 2024
Upper · Passed
Favorable with Amendments {
upper
Apr 1, 2024
Upper · Passed
Favorable with Amendments Report by Finance
upper
Mar 25, 2024
House Of Delegates · Passed
House of Delegates Vote: pass (129-0-9)
house of delegates
Mar 18, 2024
Committee
Referred Finance
upper
Mar 18, 2024
Lower · Passed
Third Reading Passed
lower
Mar 17, 2024
Senate · Passed
Senate Vote: pass (44-0-1)
senate
Mar 16, 2024
Lower · Passed
Favorable with Amendments {
lower
Mar 16, 2024
Lower · Passed
Favorable with Amendments Report by Health and Government Operations
lower
Feb 2, 2024
Committee
First Reading Health and Government Operations
lower
20 primary · 0 co-sponsors

Sponsors